IN2014DN09774A - - Google Patents

Info

Publication number
IN2014DN09774A
IN2014DN09774A IN9774DEN2014A IN2014DN09774A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A IN 9774DEN2014 A IN9774DEN2014 A IN 9774DEN2014A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A
Authority
IN
India
Prior art keywords
synthesis
activated
improved
disclosed embodiments
intermediates
Prior art date
Application number
Other languages
English (en)
Inventor
Kelly Kraft
John Freeman
Paul Serwinski
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Original Assignee
Mannkind Corp
Kelly Kraft
John Freeman
Serwin Ski Paul
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp, Kelly Kraft, John Freeman, Serwin Ski Paul, Vinnie Pavia, Otto Phantsiel, Navneet Kaur filed Critical Mannkind Corp
Publication of IN2014DN09774A publication Critical patent/IN2014DN09774A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9774DEN2014 2012-04-27 2013-03-15 IN2014DN09774A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (1)

Publication Number Publication Date
IN2014DN09774A true IN2014DN09774A (de) 2015-07-31

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9774DEN2014 IN2014DN09774A (de) 2012-04-27 2013-03-15

Country Status (16)

Country Link
US (6) US9193691B2 (de)
EP (1) EP2841422B1 (de)
JP (1) JP6241682B2 (de)
KR (1) KR20150023315A (de)
CN (2) CN107879938A (de)
AU (2) AU2013252901B2 (de)
BR (1) BR112014026809A2 (de)
CA (1) CA2871126C (de)
HK (1) HK1207382A1 (de)
IL (1) IL235247A0 (de)
IN (1) IN2014DN09774A (de)
MX (1) MX361470B (de)
RU (1) RU2014143116A (de)
SG (1) SG11201406970QA (de)
WO (1) WO2013162764A1 (de)
ZA (1) ZA201408429B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (de) 2006-02-22 2015-07-10 Mannkind Corp
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
US9193691B2 (en) * 2012-04-27 2015-11-24 Mannkind Corporation Methods for the synthesis of activated ethylfumarates and their use as intermediates
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN115894270B (zh) * 2022-10-10 2024-09-06 深圳市迪克曼生物科技有限公司 一种神经酰胺及其制备方法和应用
CN117646042B (zh) * 2023-11-13 2025-04-11 浙江工业大学 一种富马酸单酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
IN2015DN00888A (de) * 2006-02-22 2015-07-10 Mannkind Corp
EP2379511B1 (de) * 2008-12-29 2014-12-17 MannKind Corporation Substituierte diketopiperazinanaloga zur verwendung als mittel zur verabreichung von arzneimitteln
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8809382B2 (en) * 2009-05-04 2014-08-19 The Royal Institution For The Advancement Of Learning/Mcgill University 5-oxo-ETE receptor antagonist compounds
CN101851213A (zh) * 2010-06-21 2010-10-06 于清 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法
SG10201802008TA (en) 2011-02-10 2018-04-27 Mannkind Corp Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
US9193691B2 (en) * 2012-04-27 2015-11-24 Mannkind Corporation Methods for the synthesis of activated ethylfumarates and their use as intermediates

Also Published As

Publication number Publication date
US12202807B2 (en) 2025-01-21
US20190010131A1 (en) 2019-01-10
US10858325B2 (en) 2020-12-08
RU2014143116A (ru) 2016-06-20
EP2841422B1 (de) 2019-08-28
CA2871126A1 (en) 2013-10-31
EP2841422A4 (de) 2016-04-13
CN104797563B (zh) 2017-12-15
IL235247A0 (en) 2014-12-31
US20210114994A1 (en) 2021-04-22
MX361470B (es) 2018-12-06
CA2871126C (en) 2020-07-14
US20130289278A1 (en) 2013-10-31
BR112014026809A2 (pt) 2017-06-27
CN104797563A (zh) 2015-07-22
MX2014013075A (es) 2015-08-14
KR20150023315A (ko) 2015-03-05
AU2018201397B2 (en) 2019-05-02
US20230057608A1 (en) 2023-02-23
EP2841422A1 (de) 2015-03-04
HK1207382A1 (en) 2016-01-29
US9193691B2 (en) 2015-11-24
CN107879938A (zh) 2018-04-06
US11479535B2 (en) 2022-10-25
AU2013252901B2 (en) 2017-11-30
JP6241682B2 (ja) 2017-12-06
ZA201408429B (en) 2021-05-26
JP2015519321A (ja) 2015-07-09
US20160159753A1 (en) 2016-06-09
SG11201406970QA (en) 2014-11-27
AU2018201397A1 (en) 2018-03-22
US10071969B2 (en) 2018-09-11
AU2013252901A1 (en) 2014-11-06
US20250109109A1 (en) 2025-04-03
WO2013162764A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
IN2014DN09774A (de)
EP2526199A4 (de) Verfahren zur erzeugung von zinkfingernukleasen mit veränderter wirkung
MX2013004870A (es) Procedimiento para producir aerogeles o xerogeles.
MY168935A (en) Synthesis of heterocyclic compounds
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
TNSN08513A1 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
WO2012006440A3 (en) Endothelial cell production by programming
MX2012011055A (es) Metodo para preparar hexafluoro-2-buteno.
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
UA94639C2 (ru) Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
PH12016502534A1 (en) Azaquinazoline carboxamide derivatives
WO2011129636A3 (ko) 초급속연소법을 이용한 나노전극재료 합성방법 및 그 방법으로 합성된 나노전극재료
WO2015148049A3 (en) Synthesis of framework modified zsm-48 crystals
GB201103256D0 (en) Solid support and method of recovering biological material therefrom
MX346507B (es) Proceso para producir 2,3,3,3,-tetrafluoropropeno.
EP2613800A4 (de) Reifung des magen-darm-trakts
PH12012501153A1 (en) Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds